Novel Biomarkers of Thrombotic Risk

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 15, 2018

Study Completion Date

February 15, 2018

Conditions
Myocardial Infarction
Trial Locations (1)

05401

University of Vermont Medical Center, Burlington

All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

University of Vermont

OTHER

NCT02505217 - Novel Biomarkers of Thrombotic Risk | Biotech Hunter | Biotech Hunter